Copyright
©The Author(s) 2015.
World J Gastroenterol. Feb 14, 2015; 21(6): 1938-1944
Published online Feb 14, 2015. doi: 10.3748/wjg.v21.i6.1938
Published online Feb 14, 2015. doi: 10.3748/wjg.v21.i6.1938
PEG + M | AscPEG | P value | |
Age (mean ± SD, yr) | 55 ± 13.8 | 54 ± 13.7 | 0.88 |
Male subjects | 54% | 50% | 0.74 |
BMI (mean ± SD, kg/m2) | 27 ± 4.7 | 27 ± 4.9 | 0.54 |
Indication | |||
Screening | 46% | 43% | 0.70 |
Hematochezia | 13% | 13% | 0.95 |
Abdominal pain | 14% | 12% | 0.75 |
Change in bowel habits | 10% | 6% | 0.41 |
Surveillance | 7% | 9% | 0.53 |
Positive FOBT | 4% | 5% | 0.74 |
Weight loss | 2% | 1% | 0.27 |
Anemia | 2% | 5% | 0.31 |
Diverticular disease | 0% | 2% | 0.20 |
Others | 2% | 4% | 0.28 |
PEG + M | AscPEG | P value | |
Right | 84% | 79% | 0.340 |
Mid | 95% | 89% | 0.110 |
Left | 94% | 81% | 0.0051 |
Overall | 85% | 74% | 0.054 |
-
Citation: Sharara AI, Harb AH, Sarkis FS, Chalhoub JM, Badreddine R, Mourad FH, Othman M, Masri O. Split-dose menthol-enhanced PEG
vs PEG-ascorbic acid for colonoscopy preparation. World J Gastroenterol 2015; 21(6): 1938-1944 - URL: https://www.wjgnet.com/1007-9327/full/v21/i6/1938.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i6.1938